The store will not work correctly when cookies are disabled.
octadecanoic acid 2-hydroxy-2-oxo-2lambda*5*-[1,2]oxaphospholan-5-ylmethyl ester
ID: ALA215854
PubChem CID: 44415020
Max Phase: Preclinical
Molecular Formula: C22H43O5P
Molecular Weight: 418.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)OCC1CCP(=O)(O)O1
Standard InChI: InChI=1S/C22H43O5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22(23)26-20-21-18-19-28(24,25)27-21/h21H,2-20H2,1H3,(H,24,25)
Standard InChI Key: RECPERJVACZKAR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 28 0 0 0 0 0 0 0 0999 V2000
-2.2505 0.6554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4255 0.6554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1698 1.4406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8380 1.9250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5054 1.4400 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
-2.9241 2.1587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1844 0.9703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4417 1.8283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2583 1.3916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9864 1.7795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6863 1.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0146 2.6039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4145 1.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1144 1.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8426 1.6816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5426 1.2449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2708 1.6326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9707 1.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6988 1.5838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3987 1.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1269 1.5348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8268 1.0981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5550 1.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2550 1.0492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9832 1.4369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6831 1.0002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4113 1.3881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1112 0.9513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 7 1 0
13 14 1 0
2 3 1 0
14 15 1 0
15 16 1 0
3 4 1 0
16 17 1 0
3 8 1 0
17 18 1 0
4 5 1 0
18 19 1 0
8 9 1 0
19 20 1 0
5 1 1 0
20 21 1 0
9 10 1 0
21 22 1 0
1 2 1 0
22 23 1 0
10 11 1 0
23 24 1 0
5 6 2 0
24 25 1 0
10 12 2 0
25 26 1 0
26 27 1 0
11 13 1 0
27 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 418.56 | Molecular Weight (Monoisotopic): 418.2848 | AlogP: 6.77 | #Rotatable Bonds: 18 |
Polar Surface Area: 72.83 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 1.36 | CX Basic pKa: ┄ | CX LogP: 6.00 | CX LogD: 3.69 |
Aromatic Rings: ┄ | Heavy Atoms: 28 | QED Weighted: 0.15 | Np Likeness Score: 0.57 |
References
1. Xu Y, Jiang G, Tsukahara R, Fujiwara Y, Tigyi G, Prestwich GD.. (2006) Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors., 49 (17): [PMID:16913720] [10.1021/jm060351+] |